EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Lateral Guided Bone Regeneration Using a Novel Synthetic Bioresorbable Membrane: A Two Center Prospective Randomized Controlled Trial Running title: A novel membrane for ridge augmentation

Michal Halperin-Sternfeld, Hadar Zigdon-Giladi, Lior Shapira, Asaf Wilensky

Journal of Molecular and Clinical Medicine · 2018

DOI: 10.31083/j.jmcm.2018.03.006 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Molecular and Clinical Medicine, 2018. Verfasst von Michal Halperin-Sternfeld und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to evaluate the outcomes of lateral guided bone regeneration (GBR) using a novel resorbable synthetic polyethylene-glycol/methacrylate (PEG/MET) membrane compared to a non-cross-linked collagen membrane (CM). Twenty-eight patients with a potential implant site exhibiting insufficient bone width of $\leq$ 5 mm were included. Ridge width was measured intraoperatively at 1 mm and 4 mm apical to the crest and via cone-beam computed tomography at baseline and 6 months following GBR using either a PEG/MET or a CM in conjunction with an allograft. During implant placement, core biopsies were harvested and analyzed histomorphometrically. Width changes were calculated. Differences between groups were analyzed using two-sided t-test and Mann-Whitney U-test. The PEG/MET membrane was moldable and exhibited higher strength and stability compared to the CM. Nevertheless, it displayed higher exposure rate of 12/15, compared to 2/13 in the CM sites. At the time of implant insertion, 6 months following GBR, significant gain in bone width was observed in both groups. Mean ridge width at 1 mm and 4 mm apical to the crest was increased significantly from 2.06 $\pm$ 0.77 mm and 3.84 $\pm$ 1.23 mm to 3.84 $\pm$ 1.52 mm and 6.06 $\pm$ 2.03 mm ($p=$ 0.0006 and $p=$ 0.0009, respectively), with no clinical or radiographic differences between groups. Experimental sites contained more residual scaffold material than the controls (17.4 $\pm$ 3.3% and 8.6 $\pm$ 2.0%, $p=$ 0.0566). However, bone and connective tissue area fraction were not statistically different between the groups. Overall, despite the higher exposure rate, the new PEG/MET membrane was as successful as a standard collagen membrane in lateral GBR and may have potential use in bone augmentation procedures. This study suggests the feasibility of synthetic membranes, which are not associated with disease transmission, as an attractive alternative to the commonly used CM of bovine or porcine origin.

Zitieren

APA

Halperin-Sternfeld, M., Zigdon-Giladi, H., Shapira, L., & Wilensky, A. (2018). Lateral Guided Bone Regeneration Using a Novel Synthetic Bioresorbable Membrane: A Two Center Prospective Randomized Controlled Trial Running title: A novel membrane for ridge augmentation. Journal of Molecular and Clinical Medicine. https://doi.org/10.31083/j.jmcm.2018.03.006

Vancouver

Halperin-Sternfeld M, Zigdon-Giladi H, Shapira L, Wilensky A. Lateral Guided Bone Regeneration Using a Novel Synthetic Bioresorbable Membrane: A Two Center Prospective Randomized Controlled Trial Running title: A novel membrane for ridge augmentation. Journal of Molecular and Clinical Medicine. 2018. doi:10.31083/j.jmcm.2018.03.006

BibTeX
@article{HalperinSternfeld2018,
  author = {Halperin-Sternfeld, Michal and Zigdon-Giladi, Hadar and Shapira, Lior and Wilensky, Asaf},
  title = {Lateral Guided Bone Regeneration Using a Novel Synthetic Bioresorbable Membrane: A Two Center Prospective Randomized Controlled Trial Running title: A novel membrane for ridge augmentation},
  journal = {Journal of Molecular and Clinical Medicine},
  year = {2018},
  doi = {10.31083/j.jmcm.2018.03.006}
}
Kostenlos starten →